Skip to main content
Professor Gary F. Baxter

Professor Gary F. Baxter

Professor of Pharmacology

School of Pharmacy and Pharmaceutical Sciences

+44 (0)29 2068 8544
Redwood Building, King Edward VII Avenue, Cardiff, CF10 3NB


I am Professor of Pharmacology with particular research interests in cardiovascular disease and therapy. Previously, I served as Pro Vice-Chancellor, College of Biomedical and Life Sciences (2017-2020) and Head of the School of Pharmacy and Pharmaceutical Sciences (2010 to 2017). Currently I am Independent Member (University) on Cardiff and Vale University Health Board.


I qualified in pharmacy at the University of Nottingham (BPharm) and The Royal London Hospital (MRPharmS). After a short period spent in clinical practice in hospitals in East Anglia, I undertook research training in experimental pharmacology. My PhD was awarded in 1992 for studies on the modulation of ischaemia and reperfusion-induced arrhythmias in hypertensive left ventricular hypertrophy.

Supported by MRC, Wellcome Trust and British Heart Foundation grants and fellowships, I undertook postdoctoral training at UCL and The Cape Heart Centre, South Africa, before being appointed Senior Lecturer at UCL in 2001. I was appointed Reader in Cardiovascular Biology at The Royal Veterinary College, University of London, 2002-2007. I came to Cardiff  as Professor of Pharmacology in 2007.

I have been elected to Fellowships of the British Pharmacological Society, the Royal Pharmaceutical Society, the American Heart Association and the European Society of Cardiology. Previously, I served as committee member and Secretary of the British Society for Cardiovascular Research, European Secretary of the International Society for Heart Research, and Nucleus member and Treasurer of the European Society of Cardiology's Cell Biology of the Heart Working Group. I have been a member/associate editor of several editorial boards including British Journal of Pharmacology, Heart, Pharmacology and Therapeutics, Basic Research in Cardiology and Journal of Cardiovascular Pharmacology and Therapeutics.

In 2009, the higher doctorate (DSc) was conferred by the University of Nottingham for a body of published works on protective actions of autacoid mediators in ischaemic and reperfused myocardium.















I provide undergraduate project, dissertation and tutorial supervision in the MPharm programme. I have extensive experience of curriculum design, review, approval and assessment  in Cardiff and external institutions.

For several decades, ischaemic heart disease has been a leading cause of morbidity and mortality in the industrialised nations. While in the UK and USA there are trends towards a reduction in mortality from ischaemic heart disease, the condition is predicted to become the leading cause of death worldwide by 2030, outstripping death due to infectious or neoplastic disesases. Ischaemic heart disease therefore represents a significant and ongoing medical and scientific challenge.

Research interests

  • Myocardial and coronary vascular biology, with a special emphasis on the pathophysiology of acute myocardial infarction
  • Cellular basis of ischaemia-reperfusion injury and mechanisms of cardioprotection

Recent research supervision (PhD students, post doctoral associates and visiting scholars)

Qutuba Karwi BSc MSc PhD

Joao Bigares DVM, PhD

Eylem Suveren PhD

Justin S Bice BSc PhD

Osian Llwyd BSc MSc PhD

Sian James BSc PhD

David Elsey BSc, MSc, PhD

Dwaine Burley BSc PhD

Dmitra Andreou (Erasmus Scholar, University of Athens, 2011)

Meropi Mastropetrou (Erasmus Scholar, University of Athens, 2015-2016)

Abbes Cadi-Tazi (Erasmus Scholar, University of Grenoble, 2012)

Paolo Strazzacappa (Erasmus Scholar, University of Padova, 2009-2010)

Funding bodies which support our work